Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and Endotoxin Shock

clarithromycin has been researched along with Endotoxin Shock in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakura, T; Asami, T; Atarashi, K; Betsuyaku, T; Fujii, H; Hasegawa, N; Hegab, AE; Honda, K; Ishii, M; Iwata, S; Kamata, H; Kanai, T; Koyasu, S; Nakamoto, N; Namkoong, H; Suzuki, S; Tasaka, S; Yagi, K1
Bosnjak, B; Eraković Haber, V; Glojnarić, I; Hrvacić, B; Kramarić, MD; Pasalić, I; Situm, K; Tkalcević, VI1
Aoki, Y; Fukuoka, M; Hayashi, S; Nagasawa, K; Tominaga, M1

Other Studies

3 other study(ies) available for clarithromycin and Endotoxin Shock

ArticleYear
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
    PLoS pathogens, 2018, Volume: 14, Issue:4

    Topics: Animals; Anti-Bacterial Agents; CD11b Antigen; Cell Differentiation; Cell Proliferation; Clarithromycin; Gastrointestinal Hormones; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myeloid Cells; Neuropeptides; Orthomyxoviridae; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Pneumococcal; Shock, Septic; STAT3 Transcription Factor; Streptococcus pneumoniae

2018
The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Clarithromycin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Shock, Septic; Treatment Outcome; Tumor Necrosis Factor-alpha

2008
[A case of bacteremic group A streptococcus infection with organ dysfunction following a minor skin abrasion].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:11

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Humans; Male; Multiple Organ Failure; Penicillins; Shock, Septic; Skin; Streptococcal Infections; Streptococcus pyogenes

2002